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Methods: June 2008 to June 2013, 1620 cases of diabetes patients underwent coro-
nary angiography, using quantitative coronary analysis method (QCA) to cumulate the
sum of the respective integral stenosis. Coronary artery lesion is expressed by ACC/
AHA lesion types. According to the 2007 “China Adult dyslipidemia prevention
guide” TG  2.26mmol/L, HDL-C  0.88mmol/L deﬁned as high TG/ low HDL-C
level.
Results: (1) 1620 cases of diabetic patients with high TG/ and low HDL-C in
patients was 1069 cases (65.99%). (2) The coronary stenosis score of diabetic
patients with high TG/ and low HDL-C is 10.53.6; The coronary stenosis score
of diabetes mellitus was 73.5, there are signiﬁcant differences between two
groups (P<0.05). (3) in Diabetic patients with high TG/ and low HDL-C, the
lesions type of B2, C is accounted for 69.6%; in diabetes mellitus group, the
lesions type of B2, C is accounted for 47.6%. (4) Stepwise regression analysis
showed that, there is a linear relation between coronary artery stenosis degree
integral and TG, HDL-C.
Conclusions: High TG / low HDL-C may constitute a major cardiovascular risk of
diabetes residual dyslipidemia type.GW25-e0243
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Objectives: To investigate the relationship between glycosylated hemoglobin
(HbA1c) levels and severity and long-term prognosis of coronary heart disease (CHD)
with stent implantation.
Methods: 2825 consecutive patients with stent implantation were stratiﬁed into 3
groups base on the levels of HbA1c: low HbA1c group (group A, HbA1c<5.92%,
n¼1035), moderate level HbA1c group (group B, 5.92% <HbA1c<6.82%, n¼1025)
and high HbA1c group (group C, HbA1c >6.82%, n¼765).The impact of HbA1c on
the gensini score and long-term prognosis of CHD with stent implantation were
observed.
Results: After an average of 1 years of follow-up of 2825 patients in a hospital cohort.
Participants with low (<41 mmol/mol or 5.9%) or high (> 51 mmol/mol or 6.8%)
HbA1c had a higher risk of MACE, TLR than that of participants with moderate
(41-51 mmol/mol or 5.9-6.8%) HbA1c after adjusting for multiple potential con-
founders (hazard ratios ¼ 1.505, 1.478 and 1.626, 1.522, respectively). Analysis of
HbA1c as a continuous variable showed that each XX mmol/mol (1%) increase of
HbA1c was signiﬁcantly associated with a decreased risk of MACE and TLR of
53.5% and 54.2% in those with an HbA1c level of less than 41 mmol/mol (5.9%) and
with an increased risk of MACE and TLR by 9.5% and 9.2% in those with an HbA1c
level of 41 mmol/mol (5.9%) or higher, suggesting a U-shaped association between
HbA1c and risk of MACE and TLR.
Conclusions: HbA1c levels, either as a continuous variable or a categorical variable,
has a U-shaped correlation with MACE and TLR in CHD patients with stent im-
plantation, even after adjustment for multiple confounders.GW25-e0404
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Objectives: To evaluate the impact of type 2 diabetes mellitus co-morbidity on
hospitalization costs in patients with acute myocardial infarction (AMI).
Methods: Retrospective analysis of data from the case retrieval system of Qilu
Hospital of Shandong University located in Jinan city of Shandong Province was
conducted in patients with AMI from January 1, 2011 to December 31, 2012.
Results: Stent is an important factor affecting total costs of hospital admission
(b¼0.663, P¼0.000), total costs per hospital day (b¼0.561, P¼0.000), treatment
costs (b¼0.418, P¼0.000) and treatment costs per hospital day (b¼0.378,
P¼0.000) of AMI patients over follow-up period (duration of hospital stay only).
Stent is also a protective factor to prevent AHF over follow-up period (OR¼0.247,
95%CI: 0.125-0.487, P¼0.000). Diabetes group’s inpatient incidence of acute heart
failure (AHF) is higher than non-diabetes group’s (14.0% vs. 6.8%; P¼0.002).
Implementation of PCI can reduce inpatient incidence of AHF of diabetic (23.3%
vs. 4.1%, P¼0.000) and non-diabetic (14.5% vs. 2.8%, P¼0.000) patients, and
elevate inpatient incidence of event-free survival of diabetic (77% vs. 94%,
P¼0.000) and non-diabetic (86% vs. 94%, P¼0.002) patients. Diabetic patients’
incremental cost-effectiveness ratio (ICER) estimate for implementing PCI is higher
than non-diabetic patients’.C148 JACC Vol 64/16/Suppl C j October 16–1Conclusions: Diabetes does not make an impact on total hospitalization costs and
treatment costs of AMI patients, and stent is an important factor affecting hospi-
talization costs over follow-up period. From the perspective of reduction in the
inpatient incidence of AHF and increased inpatient incidence of event-free survival
after implementing PCI, implementation of PCI after an AMI in patients with dia-
betes mellitus has a higher level of cost-effectiveness than those without diabetes
mellitus.GW25-e0507
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Objectives: To evaluate the effectiveness and safety of percutaneous coronary
intervention (PCI) on unprotected left main coronary arterial (UMLCA) 2 years after
PCI owing the UMLCA PCI is a challenging technique.
Methods: A total of 90 patients with UMLCA stenosis receiving PCI through angi-
ography guidance were enrolled from Jan. 2008 to Jan. 2012. The primary endpoint
was a composite of major adverse cardiac cerebral events (MACCE), including car-
diovascular death, myocardial infarction, target vessel revascularization and all-cause
mortality at 2 years following interval.
Results: Among the total 90 patients, male patients were 74.4%, the mean age was
(63.415.2) years old. The left main ostial, shaft and bifurcation lesions were
15.6%, 25.5% and 58.9%, respectively. The UMLCA stenosis severity was
(74.612.8) %. The mean Syntax score was (19.65.2). All 90 patients were stented
successfully and 108 drug eluting stents were implanted. The mean stents length was
(16.32.4) mm and mean dilated stents diameter was (3.91.4) mm. 55 patients
(61.1%) received 1 stent implantation and 35 patients (38.9%) received 2 stent
implantation. After followed 24 months, the all-cause mortality was 5.5%, the target
vessel revascularization was 22.6% vs. 10.8% in double stents and single stent
strategy respectively, P<0.01.
Conclusions: PCI for UMLCA stenosis is safety and effectiveness. A strategy of 1 or
2 drug-eluting stents implantation for UMLCA stenosis reveal the single stent strategy
was more effective in following 2 years period. The double stents in UMLCA with
bifurcation lesions did not improve the 2-year MACCE rates. The 1 or 2 strategy of
stents implantation by the operator decision was associated with improved results, the
coronary artery bypass grafting was more effective for the UMLCA with bifurcation
lesions.GW25-e0852
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Objectives: To determine the protective value of serum Pro-BNP in the recurrence of
late atrial ﬁbrillation after pulmonary vein isolation in paroxysmal and persistent atrial
ﬁbrillation.
Methods: 94 patients in the present study had symptomatic paroxysmal AF and
had failed to respond to at least one anti-arrhythmic drug. All patients under-
went electrophysiological study and circumferential pulmonary vein isolation
(CPVI) till to achieve PV isolation. Cardiac structure and function were
measured with 2-D echocardiogram, and the cardiac biomarker N-terminal pro-
brain natriuretic peptide (NT-pro-BNP) was measured before ablation and at
long-term follow-up.
Results: After follow-ups for 12 months, 72 patients did not recurred any late atrial
ﬁbrillation. There was no signiﬁcant difference of atrioventricular structure and
function parameters and pro-BNP in patients between success group and recur-
rence group before ablation. Left atrial dimension (LAD) and pro-BNP levels fell
only after successful AF ablation and NT-pro-BNP after 12 months follow-up. A
decrease up of > 25% of the baseline value of NT-pro-BNP at follow-up had a
speciﬁcity of 90.6%, a sensitivity of 80.6 and a accuracy 84.04% for ablation
success.
Conclusions: A decrease in NT-pro-BNP after CPVI may be a marker of long-term
ablation success.GW25-e1070
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